If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
434.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.23%)
Market Cap: £1.41b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Issue of Equity

22 Feb 2022 16:32

Fidelity Special Values Plc - Issue of Equity

Fidelity Special Values Plc - Issue of Equity

PR Newswire

London, February 22

Fidelity Special Values PLC

Issue of Ordinary Shares

On 22 February 2022, Fidelity Special Values PLC (the “Company”) issued from its block listing facility of 14 December 2020, a total of 175,000 new shares: 100,000 at a price of 291.50 pence per share and 75,000 at a price of 293.00 pence per share. These shares rank pari passu with the existing Ordinary shares in issue.

Following this issue, there are 1,555,000 Ordinary shares available under the Company’s block listing facility of 14 December 2020. In addition, the Company also has 30,000,000 ordinary shares under its block listing facility of 7 February 2022.

As a result of this issue, the total number of Ordinary shares in issue now stands at 323,458,920. There are no shares held in Treasury, therefore the total number of Ordinary shares with voting rights in the Company is 323,458,920.

The above figure of Ordinary shares with voting rights (323,458,920) may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Smita Amin

For and on behalf of FIL Investments International

Company Secretary

01737 836347

22 February 2022

Date   Source Headline
14th May 20257:37 amRNSNet Asset Value(s)
13th May 20257:54 amRNSNet Asset Value(s)
12th May 20257:51 amRNSNet Asset Value(s)
9th May 20257:37 amRNSNet Asset Value(s)
8th May 20257:36 amRNSNet Asset Value(s)
7th May 20257:52 amRNSNet Asset Value(s)
6th May 20257:54 amRNSNet Asset Value(s)
2nd May 20257:46 amRNSNet Asset Value(s)
1st May 20253:44 pmPRNTotal Voting Rights
1st May 20257:47 amRNSNet Asset Value(s)
30th Apr 20257:18 amRNSNet Asset Value(s)
29th Apr 20258:09 amRNSNet Asset Value(s)
28th Apr 20258:11 amRNSNet Asset Value(s)
28th Apr 20257:30 amPRNDividend Declaration
28th Apr 20257:00 amPRNHalf-year Report
25th Apr 20257:32 amRNSNet Asset Value(s)
24th Apr 20258:00 amRNSNet Asset Value(s)
23rd Apr 20257:56 amRNSNet Asset Value(s)
22nd Apr 20253:35 pmPRNMonthly Factsheet
22nd Apr 20257:46 amRNSNet Asset Value(s)
17th Apr 20257:51 amRNSNet Asset Value(s)
16th Apr 20257:56 amRNSNet Asset Value(s)
15th Apr 20257:49 amRNSNet Asset Value(s)
14th Apr 20257:56 amRNSNet Asset Value(s)
11th Apr 20257:41 amRNSNet Asset Value(s)
10th Apr 20257:40 amRNSNet Asset Value(s)
9th Apr 20257:39 amRNSNet Asset Value(s)
8th Apr 20257:59 amRNSNet Asset Value(s)
7th Apr 20258:04 amRNSNet Asset Value(s)
4th Apr 20257:55 amRNSNet Asset Value(s)
3rd Apr 20252:11 pmPRNPortfolio Update
3rd Apr 20257:39 amRNSNet Asset Value(s)
2nd Apr 20257:33 amRNSNet Asset Value(s)
1st Apr 20254:13 pmPRNTotal Voting Rights
1st Apr 20258:30 amRNSNet Asset Value(s)
31st Mar 20257:53 amRNSNet Asset Value(s)
28th Mar 20257:50 amRNSNet Asset Value(s)
27th Mar 20257:31 amRNSNet Asset Value(s)
26th Mar 20255:26 pmPRNTransaction in Own Shares
26th Mar 20257:31 amRNSNet Asset Value(s)
25th Mar 20257:38 amRNSNet Asset Value(s)
25th Mar 20257:30 amPRNCompliance with Market Abuse Regulations
24th Mar 20256:13 pmPRNMonthly Factsheet
24th Mar 20257:29 amRNSNet Asset Value(s)
21st Mar 20257:46 amRNSNet Asset Value(s)
20th Mar 20257:21 amRNSNet Asset Value(s)
19th Mar 20257:27 amRNSNet Asset Value(s)
18th Mar 20258:04 amRNSNet Asset Value(s)
17th Mar 20257:36 amRNSNet Asset Value(s)
14th Mar 20257:46 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.